Discovery of Nivasorexant (ACT-539313): The First Selective Orexin‑1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials.

Details

Language :

English

ISSN :

00222623

Volume :

678

Issue :

4

Database :

Supplemental Index

Journal :

Journal of Medicinal Chemistry

Publication Type :

Academic Journal

Accession number :

175630350

Full Text :

https://doi.org/10.1021/acs.jmedchem.3c01894